TGTX
NASDAQ
US
TG Therapeutics, Inc. - Common Stock
$33.53
▼ $-0.05
(-0.15%)
Vol 1.5M
11
Quality Score
ok
Deep Check
2/5
ok
Rev ✓
NI ✓
>IPO ✗
Mkt Cap
$4.7B
P/E
10.6
ROE
133.3%
Margin
84.1%
D/E
40.36
Beta
1.84
52W
$25–$46
Wall Street Consensus
15 analysts · Apr 20263
Strong Buy
9
Buy
2
Hold
1
Sell
0
Strong Sell
80.0%
Buy Rating
Price Chart
Similar Stocks
MIRM
Mirum Pharmaceuticals Inc
$4.1B
PTCT
PTC Therapeutics Inc
P/E 8.1
$6.1B
ERAS
Erasca Inc
$1.1B
CAI
Caris Life Sciences Inc
$7.6B
CELC
Celcuity Inc
$4.6B
APLS
Apellis Pharmaceuticals Inc
P/E 70.7
$3.2B
IMVT
Immunovant Inc
$5.1B
APGE
Apogee Therapeutics Inc
$5.2B
DNTH
Dianthus Therapeutics Inc
$1.8B
FOLD
Amicus Therapeutics Inc
$4.4B
Earnings
Beat rate: 0.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $0.36 | $0.14 | $-0.22 |
| Sep 2025 | $0.22 | $0.16 | $-0.06 |
| Jun 2025 | $0.22 | $0.17 | $-0.05 |
| Mar 2025 | $0.19 | $0.03 | $-0.16 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 26.0% | 26.1% | 26.1% | 26.1% | 133.2% | 133.3% |
| P/E (TTM) | 94.80 | 73.27 | 94.81 | 91.28 | 10.87 | 10.58 |
| Net Margin | 19.8% | 13.3% | 13.3% | 13.3% | 84.1% | 84.1% |
| Gross Margin | 86.6% | 87.0% | 87.0% | 87.0% | 85.3% | 85.3% |
| D/E Ratio | 88.77 | 88.64 | 88.64 | 88.64 | 40.40 | 40.36 |
| Current Ratio | 3.86 | 3.86 | 3.86 | 3.86 | 3.82 | 3.82 |
Key Ratios
ROA (TTM)
60.4%
P/S (TTM)
8.90
P/B
21.1
EPS (TTM)
$2.78
CF/Share
$-0.18
Rev Growth 3Y
+266.4%
52W High
$46.48
52W Low
$25.28
$25.28
52-Week Range
$46.48
How does TGTX compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
TGTX valuation vs Biotechnology peers
P/E ratio
10.6
▼
44%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
8.9
▼
31%
below
peers
(12.9)
vs Peers
vs Industry
Pricier
P/B ratio
21.1
▲
757%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
TGTX profitability vs Biotechnology peers
ROE
133.3%
▲
298%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
84.1%
▲
129%
above
peers
(-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
85.3%
▲
9%
above
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
60.4%
▲
229%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
TGTX financial health vs Biotechnology peers
D/E ratio
40.4
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
3.8
▼
14%
below
peers
(4.4)
vs Peers
vs Industry
In line
Beta
1.8
▲
89%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
TGTX fundamentals radar
TGTX
Peer median
Industry
TGTX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio